It Used To Be Only Small Number Of Drugs Were Fast-Tracked For FDA Approval, But That’s Been Flipped On Its Head

The proportion of new drugs receiving expedited approvals has been at least 60% for each of the past five years. The result is a rising proportion of new drugs for fatal diseases that lack extensive evidence they can prolong lives. Many continue to lack that proof years after entering the market.

from Kaiser Health News https://ift.tt/2JvLuNm